Acute Onset of Disseminated Superficial Actinic Porokeratosis and Solid Malignancy Porokeratosis (PK) is a hereditary or acquired disorder of epidermal keratinization. PK presents with one or more ... Mena FN: Palvella Therapeutics Announces New QTORINTM Product Candidate, QTORINTM Pitavastatin, For The Treatment Of Disseminated Superficial Actinic Porokeratosis (DSAP), A Rare ...

Context Explanation

Palvella Therapeutics Announces New QTORINTM Product Candidate, QTORINTM Pitavastatin, For The Treatment Of Disseminated Superficial Actinic Porokeratosis (DSAP), A Rare ... Palvella's second product candidate, QTORIN pitavastatin, is currently being developed for the treatment of disseminated superficial actinic porokeratosis. For more information, please visit ... Seeking Alpha: Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare ...

Insight Material

Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare ... Porokeratosis encompasses a group of genetic disorders that share the common characteristic clinical feature of a thin, raised, threadlike border called a cornoid lamellae. The most common clinical ... The differential diagnosis of DSAP includes actinic keratosis, Darier disease, psoriasis, hereditary punctate keratoderma, porokeratotic eccrine ostial and dermal duct nevus, and lichen nitidus.